Advanced Oncotherapy – Update On Financing As the Mega Ouzo-Order Goes In
By Nigel Somerville, the Deputy Sheriff of AIM | Monday 23 October 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
AIM-listed crock Advanced Oncotherapy (AVO) which is already suspended served up an update on its financing this morning. It makes utterly grim reading: time to order in a huge delivery of Ouzo for Christmas.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.